4//SEC Filing
CureDuchenne Ventures, LLC 4
Accession 0000899243-20-026184
CIK 0001818794other
Filed
Sep 22, 8:00 PM ET
Accepted
Sep 23, 7:05 PM ET
Size
7.2 KB
Accession
0000899243-20-026184
Insider Transaction Report
Form 4
CureDuchenne Ventures, LLC
10% Owner
Transactions
- Conversion
Series A Preferred Stock
2020-09-21−2,000,000→ 0 total→ Common Stock (602,972 underlying) - Conversion
Common Stock
2020-09-21+602,972→ 602,972 total
Footnotes (1)
- [F1]On September 21, 2020, the Series A Preferred Stock automatically converted into Common Stock on a 3.3169-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
IncorporatedCA
Related Parties
1- filerCIK 0001824590
Filing Metadata
- Form type
- 4
- Filed
- Sep 22, 8:00 PM ET
- Accepted
- Sep 23, 7:05 PM ET
- Size
- 7.2 KB